TECHNOLOGYBLOOMBERG
Robeauté Bets on Rice-Sized Microrobots for Brain Disease
Robeauté, a French neurotechnology startup, is developing rice-sized microrobots designed to enable precise delivery of drugs and therapies directly into areas of the brain that are difficult to access. The company's CEO stated that Robeauté plans for first-in-human studies in 2027, with a market launch targeted for the early 2030s.
Mentioned
Related Signal
Adjacent reporting
- From decades to years - AI could speed search for brain drugs hiding in plain sight
- From decades to years - AI could speed search for brain drugs hiding in plain sight
- AI giant Anthropic creates drug research tool, plans its own studies for overlooked diseases
- A science powerhouse bets on genetic therapy to beat brain disorders
- A Brain Implant for Depression Is About to Be Tested in Humans